Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Pre-Conditioning Serum Leptin Levels Predict Early Relapse Rates of High Risk AML after Allogeneic Stem Cell Transplantation

Mark-Alexander Schwarzbich, MD, Hao Dai, Lambros Kordelas, MD, Dietrich W. Beelen, Aleksandar Radujkovic, MD, Carsten Müller-Tidow, MD, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2018) 132 (Supplement 1): 3419.

https://doi.org/10.1182/blood-2018-99-112807

Published: 2018

Journal Articles

Modulation of T-Cell Function and Immune Phenotype in the Microenvironment of Emu-TCL1 CLL Bearing Mice By Ibrutinib

Mark-Alexander Schwarzbich, Arantxa Romero-Toledo, MSc, John G. Gribben

Blood (2018) 132 (Supplement 1): 3138.

https://doi.org/10.1182/blood-2018-99-118059

Published: 2018

Journal Articles

Modulation of T-Cell Function in the Microenvironment of Emu-TCL1 CLL Bearing Mice By Btki Appears Independent of ITK

Mark-Alexander Schwarzbich, MD, Arantxa Romero-Toledo, MSc, Melanie Frigault, PhD, John G. Gribben

Blood (2018) 132 (Supplement 1): 3139.

https://doi.org/10.1182/blood-2018-99-116444

Published: 2018

Journal Articles

ATG and Statins Reduce Incidence of Severe Chronic Gvhd By Distinct Mechanisms Involving CXCL9 and Kynurenine Catabolism

Thomas Luft, MD PhD, Katharina Schmidt, MD, Karl-Heinz Kellner, PhD, Aleksandar Radujkovic, MD, Nicola Lehners, MD, Mark-Alexander Schwarzbich, MD, Ute Hegenbart, MD, Anthony D. Ho, MD, Peter Dreger, MD

Blood (2015) 126 (23): 856.

https://doi.org/10.1182/blood.V126.23.856.856

Published: 2015

Journal Articles

Minimal Renal Toxicity after Rituximab DHAP with a Modified Cisplatin Application Scheme in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Katharina Lisenko, MD, Fabienne McClanahan, MD PhD, Tilman Schöning, MD, Mark-Alexander Schwarzbich, MD, Martin Cremer, MD, Tobias Dittrich, MD, Anthony D. Ho, MD, Mathias Witzens-Harig, MD

Blood (2015) 126 (23): 1506.

https://doi.org/10.1182/blood.V126.23.1506.1506

Published: 2015

Journal Articles

Rituximab, Age and High Dose Therapy Followed By Autologus Stem Cell Transplantation Are Independent Prognostic Factors for Survival in the First Line Treatment of Primary CNS-Lymphoma

Michael Madle, Isabelle Herth, Nicola Lehners, MD, Mark-Alexander Schwarzbich, MD, Patrick Wuchter, Gerlinde Egerer, MD, Anthony D. Ho, Mathias Witzens-Harig, MD

Blood (2014) 124 (21): 1727.

https://doi.org/10.1182/blood.V124.21.1727.1727

Published: 2014

Journal Articles

Prediction of Chronic Lung Graft-Versus-Host Disease By Angiopoietin-2

Katharina Schmidt, MD, Mark-Alexander Schwarzbich, MD, Nicola Lehners, MD, Sivaramakrishna P. Rachakonda, PhD, Christine Falk, Anthony D. Ho, Prof., MD FRCPC, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2014) 124 (21): 1175.

https://doi.org/10.1182/blood.V124.21.1175.1175

Published: 2014

Journal Articles

High VEGF Serum Levels on Days +50 and +100 after Allogeneic Stem Cell Transplantation Predict Severe Chronic GvHD

Mark-Alexander Schwarzbich, MD, Lehners Nicola, MD, Katharina Schmidt, MD, Christine Falk, Anthony D. Ho, MD FRCPC, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2014) 124 (21): 1163.

https://doi.org/10.1182/blood.V124.21.1163.1163

Published: 2014

Journal Articles

Female Donors Are Associated with an Increased Risk of Chronic Graft-Versus-Host Disease (cGVHD) Independent of Recipient Sex but Provide Superior Graft-Versus-Leukemia Activity Once cGVHD Is Established

Nicola Lehners, MD, Mark-Alexander Schwarzbich, MD, Katharina Schmidt, MD, Joe Puthenparambil, MD, Aleksandar Radujkovic, MD, Sascha Dietrich, MD, Anthony D Ho, MD, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2014) 124 (21): 3917.

https://doi.org/10.1182/blood.V124.21.3917.3917

Published: 2014

Journal Articles

Immunosuppressive Drugs up-Regulate the Immunoinhibitory Receptor Osteoactivin On Human Monocyte-Derived Dendritic Cells

Sabine Braun, Michael Gutknecht, Mark-Alexander Schwarzbich, MD, Lothar Kanz, MD, Helmut R Salih, MD, Frank Grünebach, PD, Susanne M Rittig, MD

Blood (2012) 120 (21): 3284.

https://doi.org/10.1182/blood.V120.21.3284.3284

Published: 2012

Journal Articles

Immunosuppressive Drugs Upregulate the Immunoinhibitory Receptor Osteoactivin in Monocyte-Derived Dendritic Cells,

Mark-Alexander Schwarzbich, MD, Michael Gutknecht, Lisa Guettler, Lothar Kanz, MD, Helmut R. Salih, MD, Frank Gruenebach, PhD, Susanne Malaika Rittig, MD

Blood (2011) 118 (21): 3232.

https://doi.org/10.1182/blood.V118.21.3232.3232

Published: 2011

Journal Articles

Upregulation of Osteoactivin Upon Exposure to Tyrosine Kinase Inhibitors Impairs the T Cell Stimulatory Capacity of Monocyte-Derived Dendritic Cells

Michael Gutknecht, Lisa Güttler, Mark-Alexander Schwarzbich, MD, Julia Salih, Lothar Kanz, MD, Helmut R. Salih, MD, Susanne Malaika Rittig, MD, Frank Grünebach, PD

Blood (2011) 118 (21): 1112.

https://doi.org/10.1182/blood.V118.21.1112.1112

Published: 2011

Journal Articles

The Immune-Inhibitory Receptor Osteoactivin Is up-Regulated In Monocyte-Derived Dendritic Cells Upon Exposure to Tyrosine Kinase Inhibitors

Michael Gutknecht, Mark-Alexander Schwarzbich, Julia Salih, Lothar Kanz, MD, Helmut R. Salih, MD, Susanne M. Schmidt, Frank Grünebach

Blood (2010) 116 (21): 1733.

https://doi.org/10.1182/blood.V116.21.1733.1733

Published: 2010

NARROW

Pre-Conditioning Serum Leptin Levels Predict Early Relapse Rates of High Risk AML after Allogeneic Stem Cell Transplantation

Modulation of T-Cell Function and Immune Phenotype in the Microenvironment of Emu-TCL1 CLL Bearing Mice By Ibrutinib

Modulation of T-Cell Function in the Microenvironment of Emu-TCL1 CLL Bearing Mice By Btki Appears Independent of ITK

ATG and Statins Reduce Incidence of Severe Chronic Gvhd By Distinct Mechanisms Involving CXCL9 and Kynurenine Catabolism

Minimal Renal Toxicity after Rituximab DHAP with a Modified Cisplatin Application Scheme in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Rituximab, Age and High Dose Therapy Followed By Autologus Stem Cell Transplantation Are Independent Prognostic Factors for Survival in the First Line Treatment of Primary CNS-Lymphoma

Prediction of Chronic Lung Graft-Versus-Host Disease By Angiopoietin-2

High VEGF Serum Levels on Days +50 and +100 after Allogeneic Stem Cell Transplantation Predict Severe Chronic GvHD

Female Donors Are Associated with an Increased Risk of Chronic Graft-Versus-Host Disease (cGVHD) Independent of Recipient Sex but Provide Superior Graft-Versus-Leukemia Activity Once cGVHD Is Established

Immunosuppressive Drugs up-Regulate the Immunoinhibitory Receptor Osteoactivin On Human Monocyte-Derived Dendritic Cells

Immunosuppressive Drugs Upregulate the Immunoinhibitory Receptor Osteoactivin in Monocyte-Derived Dendritic Cells,

Upregulation of Osteoactivin Upon Exposure to Tyrosine Kinase Inhibitors Impairs the T Cell Stimulatory Capacity of Monocyte-Derived Dendritic Cells

The Immune-Inhibitory Receptor Osteoactivin Is up-Regulated In Monocyte-Derived Dendritic Cells Upon Exposure to Tyrosine Kinase Inhibitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only